跳至主要内容
临床试验/NCT06879509
NCT06879509
尚未招募
不适用

The Use of Thromboelastography in Burn Injury to Improve Burn Coagulopathy Evaluation and Intervention

Francesco Egro1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年6月最近更新:

概览

阶段
不适用
状态
尚未招募
发起方
Francesco Egro
入组人数
50
试验地点
1
主要终点
Thromboelastography

概览

简要总结

This pilot study examines the use of thromboelastography (TEG), a specialized blood test, to evaluate clotting abnormalities in burn patients. The study aims to understand how burn injuries impact the body's ability to form and break down blood clots over time. Specifically, the investigators will research whether the percentage of total body surface area burned (%TBSA) is associated with changes in blood clotting, track the evolution of clotting patterns during the first four weeks following a burn injury, and explore whether these changes can predict recovery or complications. By providing new insights into clotting dynamics in burn patients, the study seeks to improve diagnostic methods, enhance monitoring strategies, and guide treatments to optimize patient care and outcomes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted with acute burn injuries
  • Aged 18 years and older
  • Provided consent to participate in the study

排除标准

  • Patients with a history of venous thromboembolism or hyper/hypocoagulopathy

结局指标

主要结局

Thromboelastography

时间窗: Duration of hospital length of stay, up to 28 days

Thromboelastography (TEG) evaluates blood's clotting ability by measuring the strength and elasticity of a clot over time, producing a dynamic graph. The following outcome measures will be assessed at specific time points (Day 1, Day 7, Day 14, Day 21, and Day 28): 1. Reaction Time (R) (seconds) - The time from test initiation until the first detectable clot formation. 2. Kinetic Time (K) (seconds) - The time from initial clot formation to a defined clot strength threshold. 3. Maximum Amplitude (MA) (millimeters) - The peak strength of the formed clot. 4. Alpha Angle (degrees) - The slope of the clot formation curve, representing the rate of clot development. 5. Lysis at 30 Minutes (Ly30) (percentage of MA) - The percentage of clot degradation occurring 30 minutes after reaching maximum amplitude. Each parameter will be measured at the specified time points, and values will be aggregated into one TEG graph.

次要结局

  • Hospital Length of Stay(Duration of hospital length of stay, up to 28 days)
  • Complications During Treatment(Duration of hospital length of stay, up to 28 days)

研究者

发起方
Francesco Egro
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Francesco Egro

Associate Professor

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验